Tarig Bashir is the founder of FoRx Therapeutics. FoRx Therapeutics has raised $61M in total funding. Latest round: Series A. Based in Basel, Switzerland.
Tarig Bashir is the Chief Executive Officer of FoRx Therapeutics, a Basel-based clinical-stage biotechnology company. He leads the company's efforts to advance its lead PARG inhibitor, FORX-428, which is currently in Phase 1 trials for advanced solid tumors.
Full founder directory · Investor directory · Company funding database · Fundraising library